WHAT WE DO
WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $4 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
 
OUR AREAS
INVESTMENT MANAGEMENT

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

m&a AND STRATEGIC ADVISORY

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.  

INVESTMENT BANKING

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.  

institutional sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

equity research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

EQUITY Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

PRESS RELEASES

VIEW ALL

WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.

WBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.
CONTINUE READING

WBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit Facility

WBB Securities acted as financial advisor to T2 Biosystems, Inc., a manufacturer of next generation diagnostic equipment, for a credit…
CONTINUE READING

WBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics

WBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.
CONTINUE READING

OPINIONS & FEATURES

VIEW ALL

Why The Street Should Fear The Senate Healthcare Bill

As the Republican Senate majority unveiled its draft healthcare bill Thursday, there was a rally in healthcare stocks in anticipation…
CONTINUE READING

Why Healthcare Reform Won’t Be Rushed — And It Isn’t Political

Republicans learned that they must tread carefully in their plans to replace the ACA as the consequences of their actions…
CONTINUE READING

Trump, Interest Rates, And Biotech Investing In 2017

We are heading into 2017 with a great deal of uncertainty, but if President-elect Trump governs the nation as he…
CONTINUE READING